Paul ashton
Company: Inflammasome Therapeutics
Job title: President & Chief Executive Officer
Seminars:
Inhibiting Caspase-1 & Inflammasome Activation: Preclinical Data & Clinical Observations 11:00 am
Inhibiting caspase-1 and inflammasome activation in vivo Reversing cognitive decline in 5XFAD mice Clinical use associated with reduced incidence of ADRead more
day: Discovery Track Day 2 AM